title: [IgA nephropathy and intrahepatic percutaneous portosystemic shunt].
authors.forename: S
authors.initials: S
authors.lastname: Blanco Sampascual
authors.forename: B
authors.initials: B
authors.lastname: de las Heras Niño
authors.forename: L
authors.initials: L
authors.lastname: Marcé Landeta
authors.forename: V
authors.initials: V
authors.lastname: Orive Cura
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016030:Kidney Transplantation; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone